ELOX · Eloxx Pharmaceuticals, Inc. · Debt
$13.15
+0.26 (+2.02%)
At close · Nov 13
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$53.08M
Shares
4.04M
Volume · Nov 13
14.78K
Avg daily vol (3M)
30.68K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of long-term debt | 2026-06-30 | USD 0 | 10-Q filed 2026-08-11 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1035354
CUSIP
29014R301
13F (30d)
14 filings
14 filers
Visit website
Investor relations